Healthcare Services

Neurofeedback Market Expected To Witness Revenue Growth Toward $2.59 Billion By 2030

June 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Size Of The Neurofeedback Market Progress Through 2030?

The neurofeedback market has seen rapid expansion in recent years. Its value is expected to rise from $1.57 billion in 2025 to $1.74 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.8%. This historic growth can be linked to greater awareness of mental health treatments, an increase in neurological disorders, the development of alternative and non-invasive therapies, the growth of neurotherapy clinics, and the availability of EEG monitoring technologies.

The neurofeedback market is anticipated to experience substantial growth in the upcoming years. It is projected to reach $2.6 billion by 2030, demonstrating a compound annual growth rate of 10.5%. This expansion during the forecast period is driven by the escalating demand for personalized mental health treatments, the increasing embrace of digital therapeutics, the proliferation of remote neurofeedback training, the growing incorporation of AI in brain signal analysis, and a sharpened focus on optimizing cognitive wellness. Prominent trends for this period include the wider adoption of EEG-based training systems, the rising implementation of personalized neurofeedback protocols, the deeper integration of software-based brain training tools, the broadening availability of home-based neurofeedback solutions, and an enhanced dedication to improving cognitive performance.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20577&type=smp

What Core Drivers Are Transforming The Neurofeedback Market?

The rising occurrence of neurodegenerative conditions is anticipated to drive expansion in the neurofeedback market in the future. These diseases are ailments characterized by a gradual deterioration of brain and nervous system function, resulting in impairments in memory, mobility, and cognition. This surge in neurodegenerative conditions is largely attributable to an aging populace, enhanced diagnostic capabilities and public understanding, and various lifestyle elements. Neurofeedback serves as a significant aid in addressing Parkinson’s disease, assisting in the enhancement of motor skills, cognitive abilities, emotional balance, and general brain well-being. Furthermore, neurofeedback can be utilized to ameliorate sleep quality, frequently disturbed in individuals with Parkinson’s; by optimizing brainwave activities conducive to restorative sleep, patients could achieve improved overall health and symptom control. For example, data from March 2023, released by the Alzheimer’s Association, a US-based nonprofit voluntary health organization, indicated that in 2023, around 6.7 million Americans aged 65 and older were afflicted with Alzheimer’s dementia, with projections showing this figure reaching 13.8 million by 2060. Consequently, the expanding occurrence of neurodegenerative disorders is fueling the expansion of the neurofeedback market.

How Is The Neurofeedback Market Examined Through Segment Analysis?

The neurofeedback market covered in this report is segmented –

1) By Product: Amplifiers, Electrodes or Sensors, Computer Software

2) By System: Frequency Or Power Neurofeedback System, Slow Cortical Potential Neurofeedback (SCP-NF) System, Low-Energy Neurofeedback System (LENS), Hemoencephalographic (HEG) Neurofeedback System, Live Z-Score Neurofeedback System, Low-Resolution Electromagnetic Tomography (LORE-TA)

3) By Application: Attention Deficit Hyperactivity Disorder (ADHD), Anxiety, Depression, Epilepsy, Insomnia, Drug Addiction, Schizophrenia, Other Applications

4) By End User: Hospitals, Physician Offices

Subsegments:

1) By Amplifiers: EEG Amplifiers, Wireless Amplifiers, Portable Amplifiers

2) By Electrodes or Sensors: EEG Electrodes, Disposable Electrodes, Dry Electrodes, Conductive Gel Electrodes

3) By Computer Software: Neurofeedback Training Software, Data Analysis Software, Visualization Software, Biofeedback Software

What Trends Are Driving Changes In The Neurofeedback Market?

Major companies operating in the neuroendocrine tumor treatment market are concentrating on developing advanced therapeutic solutions, such as radioligand therapies, to improve clinical outcomes and expand treatment options for patients with GEP-NETs. Radioligand therapy represents a targeted treatment approach that delivers radioactive isotopes directly to tumor cells expressing specific receptors, enabling precise tumor cell destruction while minimizing damage to surrounding tissues. For instance, in April 2024, Novartis, a Switzerland-based healthcare company, announced the U.S. Food and Drug Administration (FDA) approval of Lutathera, the first radioligand therapy specifically indicated for pediatric patients aged 12 years and older with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors. This approval broadens access to targeted radiopharmaceutical treatment for younger NET patients and reinforces the growing role of radioligand therapies in enhancing treatment efficacy, clinical decision-making, and patient care.

Which Organizations Are Operating Within The Neurofeedback Market?

Major companies operating in the neurofeedback market are Thought Technology Ltd., NeurOptimal, Brain Master Technologies Inc., Mind Media Inc., Neurofield Inc., Bee Medic LLC, Mitsar Co. Ltd., Mind Alive Inc., ANT Neuro b.v., EEG Info, NeuroSky, EMOTIV Inc., Neuroelectrics, Brain Vision LLC, Myndlift, BrainCore, NIRx Medical Technologies LLC, Mindfield Biosystems Ltd., NeuroCare Group, Brainquiry

Access The Complete Neurofeedback Market Report:

https://www.thebusinessresearchcompany.com/report/neurofeedback-global-market-report

What Is The Largest Regional Market In The Neurofeedback Market?

North America was the largest region in the neurofeedback market in 2025. The regions covered in the neurofeedback market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Neurofeedback Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=20577&type=smp

Browse Through More Reports Similar to the Global Neurofeedback Market 2026, By The Business Research Company

Brain Tumor Drugs Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/brain-tumor-drugs-global-market-report

Glioma Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/glioma-treatment-global-market-report

Thyroid Cancer Drugs Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795